{"acute coronary syndrome": 2.1, "acute leukaemia": 11.97, "acute myeloid leukaemia": 19.13, "acute myocardial infarction": 3.28, "acute respiratory distress syndrome": 3.22, "acute respiratory failure": 3.26, "adverse drug reaction": 2.64, "anaemia": 2.2, "antibody test positive": 21.1, "aplastic anaemia": 10.84, "ascites": 2.17, "atelectasis": 5.43, "bacteraemia": 3.83, "biopsy bone marrow abnormal": 637.88, "blast cell count increased": 14.63, "blood blister": 16.23, "bone marrow disorder": 38.33, "bone marrow failure": 3.26, "cardiac arrest": 2.73, "cardiac failure congestive": 2.7, "cardiac operation": 3.42, "cardiomyopathy": 2.22, "cerebrovascular accident": 2.05, "chronic lymphocytic leukaemia": 56.84, "chronic myeloid leukaemia": 6.42, "chronic myelomonocytic leukaemia": 101.23, "chronic obstructive pulmonary disease": 3.25, "colon cancer": 2.75, "contusion": 4.08, "death": 4.75, "deep vein thrombosis": 5.88, "drug ineffective": 6.02, "ecchymosis": 11.35, "embolic stroke": 4.69, "embolism": 16.56, "end stage renal disease": 2.89, "epistaxis": 3.7, "evans syndrome": 76.2, "failure to thrive": 10.21, "fibrosis": 14.21, "gastrointestinal haemorrhage": 3.21, "gingival bleeding": 6.14, "haematological malignancy": 144.64, "haematuria": 2.37, "haemolysis": 2.14, "haemolytic anaemia": 3.91, "haemorrhage": 5.94, "haemorrhage intracranial": 6.55, "haemorrhagic diathesis": 7.57, "hepatic cirrhosis": 6.35, "hepatic encephalopathy": 2.32, "hospitalisation": 11.3, "immune thrombocytopenia": 16.25, "immunosuppression": 5.57, "increased tendency to bruise": 6.85, "iron deficiency anaemia": 2.94, "laboratory test abnormal": 2.36, "leukaemia": 6.71, "leukocytosis": 14.08, "loss of therapeutic response": 8.61, "lung cancer metastatic": 11.22, "lung infiltration": 2.21, "lung neoplasm malignant": 4.81, "lymphoma": 11.28, "malnutrition": 7.61, "marrow hyperplasia": 40.41, "megakaryocytes increased": 133.89, "mental status changes": 2.1, "mouth haemorrhage": 14.28, "mucosal haemorrhage": 33.28, "multimorbidity": 70.53, "multiple organ dysfunction syndrome": 2.04, "myelodysplastic syndrome": 43.55, "myelofibrosis": 219.29, "myeloproliferative neoplasm": 39.93, "neutrophilia": 9.51, "non-hodgkin's lymphoma": 20.31, "oedema peripheral": 2.31, "ovarian cancer": 8.1, "pancytopenia": 3.25, "petechiae": 11.54, "plasma cell myeloma": 3.7, "platelet count abnormal": 449.36, "platelet count decreased": 26.53, "platelet count increased": 67.08, "platelet disorder": 28.7, "pleural effusion": 4.45, "pneumonia": 2.27, "portal vein thrombosis": 7.79, "post procedural complication": 4.16, "prostate cancer": 2.82, "pulmonary embolism": 3.35, "pulmonary haemorrhage": 4.66, "purpura": 5.83, "refusal of treatment by patient": 39.16, "respiratory failure": 4.21, "sepsis": 4.51, "skin haemorrhage": 4.96, "splenectomy": 305.92, "splenomegaly": 9.3, "subdural haematoma": 3.77, "surgery": 3.85, "systemic lupus erythematosus": 2.11, "therapeutic product effect decreased": 11.23, "therapeutic product effect incomplete": 2.07, "therapeutic response decreased": 105.91, "therapy non-responder": 9.2, "thrombocytopenia": 9.27, "thrombocytosis": 48.37, "thrombosis": 3.64, "treatment noncompliance": 2.72, "unevaluable event": 3.69, "venous thrombosis": 3.01, "viral infection": 2.63, "white blood cell count increased": 4.44}